Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

New York center hits survival with a 92.6% one-year rate for first-time allogeneic stem cell transplants, surpassing national benchmarks.

The beloved actress shared the news on Instagram this week that she has received a kidney transplant just months after ...

For luxury travellers who value measurable wellbeing over quick fixes, Six Senses Fiji has crafted a Detox Program ...

Apple Inc (NASDAQ:AAPL, XETRA:APC) announced a new multiyear agreement with Broadcom Inc (NASDAQ:AVGO, XETRA:1YD) valued at ...

California's law requires school districts to adopt cellphone policies by July 1, Here's how Sacramento-area campuses are ...

The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials ...

Bijou Phillips has undergone a kidney transplant, five months after going public with her urgent need to find a donor.

Apple said Wednesday that it plans to spend more than $30 billion on chips produced in the United States by Broadcom, which ...

Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...

Copa Airlines isn’t listing rates but will comp service for passengers in business class, with sufficient elite status, or ...

Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress peripheral immune cells at the same dose.